A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti‑inflammatory mechanisms

Wang,Fei; Shang,Yanchang; Zhang,Rong; Gao,Xiangyang; Zeng,Qiang

doi:10.3892/mmr.2018.9699

A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti‑inflammatory mechanisms

Authors:
- Fei Wang
- Yanchang Shang
- Rong Zhang
- Xiangyang Gao
- Qiang Zeng
View Affiliations

Affiliations: Health Management Institute, Chinese PLA General Hospital, Beijing 100853, P.R. China, Department of Geriatric Neurology, Chinese PLA General Hospital, Beijing 100853, P.R. China
Published online on: November 27, 2018 https://doi.org/10.3892/mmr.2018.9699
Pages: 1040-1048
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sirtuin 1 (SIRT1) is an NAD+‑dependent protein deacetylase that is involved in cell differentiation, aging, apoptosis, physiological rhythms, metabolic regulation, oxidative stress and numerous other important biological processes. In the present study, the ability of a sirtuin‑1 (SIRT1) agonist, SRT1720, to reduce cognitive decline in type 2 diabetes mellitus (T2DM) was investigated. Streptozotocin‑induced male Sprague‑Dawley rats were used to establish a T2DM model and the protective effect of SRT1720 and its underlying mechanisms were investigated. Body weight and fasting blood glucose (FBG) were recorded and cognitive function was measured with the Morris water maze. Levels of oxidative stress, inflammation, caspase‑3 activity and nuclear factor κB (NF‑κB) mRNA expression were detected with a series of commercial assay kits and reverse transcription‑quantitative polymerase chain reaction, respectively. Western blot analysis was performed to determine the protein expression of NF‑κB, endothelial nitric oxide synthase (eNOS), peroxisome proliferator‑activated receptor γ (PPARγ), AMP‑activated protein kinase (AMPK), heat shock 70 kDa protein (HSP70), SIRT1, nuclear factor erythroid 2‑related factor 2 (Nrf2) and heme oxygenase 1 (HO‑1). The results revealed that SRT1720 significantly increased body weight, decreased FBG, improved cognitive function and reduced the levels of proteins associated with oxidative stress and inflammation damage in T2DM rats. Additionally, SRT1720 significantly decreased NF‑κB p65 mRNA expression and increased eNOS and PPARγ expression. SRT1720 significantly reduced caspase‑3 activity and HSP70 protein expression, and increased p‑AMPK, SIRT1, Nrf2 and HO‑1 protein expression. Collectively, the results indicate that SRT1720 may reduce cognitive decline in T2DM rats through antioxidative and anti‑inflammatory action via NF‑κB and AMPK‑dependent mechanisms.

View Figures

View References

1	Shikora S, Toouli J, Herrera MF, Kulseng B, Zulewski H, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, et al: Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes. 2013:2456832013. View Article : Google Scholar : PubMed/NCBI
2	Fonseca VA, Ferrannini E, Wilding JP, Wilpshaar W, Dhanjal P, Ball G and Klasen S: Active- and placebo-controlled dose-finding study to assess the efficacy, safety and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus. J Diabetes Complications. 27:268–273. 2013. View Article : Google Scholar : PubMed/NCBI
3	Liang L, Stone RC, Stojadinovic O, Ramirez H, Pastar I, Maione AG, Smith A, Yanez V, Veves A, Kirsner RS, et al: Integrative analysis of miRNA and mRNA paired expression profiling of primary fibroblast derived from diabetic foot ulcers reveals multiple impaired cellular functions. Wound Repair Regen. 24:943–953. 2016. View Article : Google Scholar : PubMed/NCBI
4	Zhang J, Sun XJ, Chen J, Hu ZW, Wang L, Gu DM and Wang AP: Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy. J Diabetes Complications. 31:241–244. 2017. View Article : Google Scholar : PubMed/NCBI
5	Madhyastha R, Madhyastha H, Pengjam Y, Nakajima Y, Omura S and Maruyama M: NFkappaB activation is essential for miR-21 induction by TGFβ1 in high glucose conditions. Biochem Biophys Res Commun. 451:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
6	Wang T, He R, Zhao J, Mei JC, Shao MZ, Pan Y, Zhang J, Wu HS, Yu M, Yan WC, et al: Negative pressure wound therapy inhibits inflammation and upregulates activating transcription factor-3 and downregulates nuclear factor-kB in diabetic patients with foot ulcerations. Diabetes Metab Res Rev. 33:2017.doi: 10.1002/dmrr.2871. View Article : Google Scholar
7	Bhat MA and Gandhi G: Elevated oxidative DNA damage in patients with coronary artery disease and its association with oxidative stress biomarkers. Acta Cardiol. 1–8. 2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
8	Yang B, Xu B, Zhao H, Wang YB, Zhang J, Li CW, Wu Q, Cao YK, Li Y and Cao F: Dioscin protects against coronary heart disease by reducing oxidative stress and inflammation via Sirt1/Nrf2 and p38 MAPK pathways. Mol Med Rep. 18:973–980. 2018.PubMed/NCBI
9	Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 450:712–716. 2007. View Article : Google Scholar : PubMed/NCBI
10	Wilmot EG, Davies MJ, Edwardson CL, Gorely T, Khunti K, Nimmo M, Yates T and Biddle SJ: Rationale and study design for a randomised controlled trial to reduce sedentary time in adults at risk of type 2 diabetes mellitus: Project stand (Sedentary Time ANd diabetes). BMC Public Health. 11:9082011. View Article : Google Scholar : PubMed/NCBI
11	Shah PS, Todkar JS and Shah SS: Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis. 6:138–141. 2010. View Article : Google Scholar : PubMed/NCBI
12	Ding P, Ren D, He S, He M, Zhang G, Chen Y, Sang H, Peng Z and Yan W: Sirt1 mediates improvement in cognitive defects induced by focal cerebral ischemia following hyperbaric oxygen preconditioning in rats. Physiol Res. 66:1029–1039. 2017.PubMed/NCBI
13	Palmer R, Nyman E, Penney M, Marley A, Cedersund G and Agoram B: Effects of IL-1β-blocking therapies in type 2 diabetes mellitus: A quantitative systems pharmacology modeling approach to explore underlying mechanisms. CPT Pharmacometrics Syst Pharmacol. 3:e1182014. View Article : Google Scholar : PubMed/NCBI
14	Raja L, Palanivelu S and Panchanatham S: Anti-inflammatory property of Kalpaamruthaa on myocardium in type 2 diabetes mellitus induced cardiovascular complication. Immunopharmacol Immunotoxicol. 35:119–125. 2013. View Article : Google Scholar : PubMed/NCBI
15	Yang J, Zhao P, Wan D, Zhou Q, Wang C, Shu G, Mei Z and Yang X: Antidiabetic effect of methanolic extract from berberis julianae Schneid. via activation of AMP-activated protein kinase in type 2 diabetic mice. Evid Based Complement Alternat Med. 2014:1062062014. View Article : Google Scholar : PubMed/NCBI
16	Russo GL, Russo M and Ungaro P: AMP-activated protein kinase: A target for old drugs against diabetes and cancer. Biochem Pharmacol. 86:339–350. 2013. View Article : Google Scholar : PubMed/NCBI
17	Yang RH, Lin J, Hou XH, Cao R, Yu F, Liu HQ, Ji AL, Xu XN, Zhang L and Wang F: Effect of docosahexaenoic acid on hippocampal neurons in high-glucose condition: Involvement of PI3K/AKT/nuclear factor-kB-mediated inflammatory pathways. Neuroscience. 274:218–228. 2014. View Article : Google Scholar : PubMed/NCBI
18	Liu S, Xu J, Fang C, Shi C, Zhang X, Yu B and Yin Y: Over-expression of heat shock protein 70 protects mice against lung ischemia/reperfusion injury through SIRT1/AMPK/eNOS pathway. Am J Transl Res. 8:4394–4404. 2016.PubMed/NCBI
19	Kuo YR, Chien CM, Kuo MJ, Wang FS, Huang EY and Wang CJ: Endothelin-1 expression associated with lipid peroxidation and nuclear factor-kB activation in type 2 diabetes mellitus patients with angiopathy and limb amputation. Plast Reconstr Surg. 137:187e–195e. 2016. View Article : Google Scholar : PubMed/NCBI
20	Xue F, Huang JW, Ding PY, Zang HG, Kou ZJ, Li T, Fan J, Peng ZW and Yan WJ: Nrf2/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning. Behav Brain Res. 309:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
21	Liu X, Ma Y, Wei X and Fan T: Neuroprotective effect of licochalcone A against oxygen-glucose deprivation/reperfusion in rat primary cortical neurons by attenuating oxidative stress injury and inflammatory response via the SIRT1/Nrf2 pathway. J Cell Biochem. 119:3210–3219. 2018. View Article : Google Scholar : PubMed/NCBI
22	Tsarouhas K, Tsitsimpikou C, Papantoni X, Lazaridou D, Koutouzis M, Mazzaris S, Rezaee R, Mamoulakis C, Georgoulias P, Nepka C, et al: Oxidative stress and kidney injury in trans-radial catheterization. Biomed Rep. 8:417–425. 2018.PubMed/NCBI
23	Prasad K and Dhar I: Oxidative stress as a mechanism of added sugar-induced cardiovascular disease. Int J Angiol. 23:217–226. 2014. View Article : Google Scholar : PubMed/NCBI
24	Bicer M, Senturk T, Yanar M, Tutuncu A, Oral AY, Ulukaya E, Serdar Z and Signak IS: Effects of off-pump versus on-pump coronary artery bypass grafting: Apoptosis, inflammation and oxidative stress. Heart Surg Forum. 17:E271–E276. 2014. View Article : Google Scholar : PubMed/NCBI
25	Liu X, Yang T, Sun T and Shao K: SIRT1-mediated regulation of oxidative stress induced by Pseudomonas aeruginosa lipopolysaccharides in human alveolar epithelial cells. Mol Med Rep. 15:813–818. 2017. View Article : Google Scholar : PubMed/NCBI